| Articles on
USP 797
"Revising
the Medicare Model Guidelines",
(c)
United States
Pharmacopeia (USP), 2/06
In addition to creating the Model Guidelines, the
Medicare Modernization Act also designates USP "to revise
such classification from time to time to reflect changes
in therapeutic uses of covered part D drugs and additions
of new covered part D drugs." The links below provide
additional information regarding USP's approach to the
revision process.
First Revision to the USP Model
Guidelines
As required under the Medicare Modernization Act, USP
has revised the Medicare prescription drug benefit Model
Guidelines. The revised Model Guidelines – Model
Guidelines Version 2.0 – may be used by drug plans as they
design their formularies for the 2007 benefit year.
Model Guidelines Expert Committee
The Model Guidelines Expert Committee is made up of
expert volunteers and will be responsible for the Model
Guidelines revisions.
The revision process will, like the initial development
process before it, be characterized by transparency,
independence, and objectivity.
Any and all interested parties will have an opportunity
to provide input into the revision process.
|
